In addition, p66Shc, in association with SNTA1 and Grb2, has been reported to enhance the metastatic activity of breast cancers by enhancing Rac1 activity (Ali et al., 2021; Ali et al., 2022). Here, RAC1 is linked to breast carcinoma.